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ABSTRACT
Psychotherapy with the use of high-dose psychedelic drugs shows immense promise in treating a
myriad of debilitating psychiatric conditions. After a three-decade long suspension, regulators have
allowed for new studies and re-awakened interest in the potential of psychedelics. However, while
research on the topic has quickly progressed, little has been done to reinvigorate our clinical
understanding of the psychedelic healing process. This thesis interprets the psychedelic state through the
twin perspectives of existentialism and neuroscience with the goal of starting to develop a theoretical
language.
The subjective experience of high-dose psychedelics under therapeutic conditions often results in
a loss-of-self referred to as ‘ego-death’. Ego-death is sometimes accompanied by fearful experiences
which people compare to mortal terror, and is a strong predictor of therapeutic success. Based on these
observations, Irving Yalom’s existential theory provides a helpful framework from which to interpret
these experiences and understand the powerful emotions that arise during the psychedelic state.
Interestingly, the biologically-based neuroscience approach compliments the subjective language of
existentialism by providing supporting observations about brain activity during ego-death. That these
experiences are predictable and observable give credence to their importance.
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CHAPTER ONE
Introduction
I had the strong impression that things can be seen, which usually rest under the surface…a lot of
emotions were hidden for a long time that are usually not noticed at all [but] became very, very
present in that state when you have a break-through somehow… – Patient #12 from a recent study
in which LSD was given to people suffering from terminal illness (Gasser et al., 2014b).
What is Psychedelic Psychotherapy?
In the most basic form, this thesis explores a therapeutic intervention that takes advantage of an
alteration of consciousness induced by psychedelics substances. Jefferey Guss is a professor of psychiatry
and runs the psychedelic psychotherapy training program at New York University. He defines
psychedelic psychotherapy as “a collection of psychotherapeutic processes that are facilitated by
psychedelic agents” (Guss, 2013). The reason for such a broad definition is that the psychedelics are
catalysts and not the therapy alone. The nature of the therapy depends on the goals of treatment. A
typical protocol will be examined in the next chapter; however, a brief explanation of the most widely
accepted therapies may be helpful.
There are two main strands of psychotherapy with psychedelics. The first utilizes low-doses of
drug within a long-term therapeutic relationship. In this form the therapy utilizes psychedelics to
accelerate the therapy process by allowing a loosening of defenses and amplifying the transferential
relationship between client and clinician. This form, known as psycholytic therapy, so named because it
is thought to aid the relaxation of ego defenses (from the Greek lusis meaning loosening) and to make the
underlying psychic conflicts more accessible (Grof, 1980). Psycholytic therapy leans heavily upon the
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relationship between client and clinician and often relies on numerous sessions with low-dose
psychedelics.
The second form of therapy is generally referred to simply as psychedelic psychotherapy and uses
psychotherapy as a preparation for, and integration of, high-dose psychedelic experiences (Grof, 1980).
Clients are given support throughout their drug experience, however, the experience is largely internal. In
psychedelic psychotherapy clients are often given eye-covers and music to help them maintain an inward
gaze instead of engaging in conversation. In this way it does not rely on the transference relationship to
uncover dynamic patterns. This thesis is focused upon this high-dose psychedelic psychotherapy
which has been the primary subject of the recent revival in research.
Historical & Legal Information
The historic use of psychedelics extends into the distant past and has been maintained primarily
in spiritual or religious ceremonies. Such a history is too broad to be fully summarized here. However,
I’ve made an attempt to synthesize important themes in their use and provide sufficient detail to illustrate
the breadth of their use across the world. The traditional methods in which psychedelics were (and
continue to be) used have many similarities in approach to current therapeutic protocols. It should then be
no surprise that people receiving psychedelics in either traditional or therapeutic contexts report similar
experiences often culminating in mystical states.
Evidence supports the widespread use of psychoactive substances throughout human history.
Merlin (2003) reviewed data on some of the substances which suggest that ephedra had been used 40,000
years ago and the earliest evidence of cannabis use dates back 10,000 years. Direct evidence for the use
of specific plants is often difficult to obtain because plant matter breaks down readily.
There is a growing body of evidence that psychedelic substances have been used by human
societies for millennia, of which I’ve chosen a small piece to present here. For further information on this
growing field please see Rauch and Hoffman’s exhaustive Encyclopaedia of Psychoactive Plants (2005).
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Recent radiocarbon dating of peyote samples discovered at archeological sites in Texas found that some
samples were 5,700 years old (or date to ~3,700 B.C.E), while another related sample is 835 years old
suggesting that there may have been continuous use of peyote for several millennia (El-Seedi, De Smet,
Beck, Possnert, & Bruhn, 2005; Terry, Steelman, Guilderson, Dering, Rowe, 2006). Amazingly, El-Seedi
and colleagues (2005) were able to extract mescaline from samples of peyote believed to be 5,700 years
old, proving that these samples did indeed contain psychoactive substances. The peyote samples
benefitted from the dry desert climate of Texas, whereas evidence in other parts of the world has had to
rely more on human creation such as drawings or carvings. The most famous of these human creations
are the 3,000 year old “mushroom stones” of Central America which depict a large mushroom cap with
figures of humans or animals carved into the mushroom stem (Metzner, 2005 from Sacred Mushrooms of
Visions introduction). After the Spanish colonial conquest in the 16th century there is documentation of
the use of psilocybin mushrooms (along with other psychoactive compounds). The most extraordinary
document was captured by Bernadino de Sahagun, a Spanish missionary who served in Mexico from
1529 to 1590. He carefully wrote down his experiences in what is known today as the Floretine Codex
(Sahagun, 2002). Eugenia Bone, in her lovely book Mycophilia explains:
De Sahagun describes the teonanactl ceremony (teo = God, nanactl = mushroom, or possibly
flesh) in which the people drank chocolate and ate the mushrooms with honey. ‘And when the
effect of the mushrooms had left them, they consulted among themselves and told one another
what they had seen in visions’ (Bone, 2011, Mycophilia p.245).
Unfortunately Spanish rule included distaste for these native intoxicants as evidenced by early Spanish
literature for people arriving in the colonies:
In 1656, a guide for missionaries argued against Indian idolatires, including mushroom ingestion,
and recommended their extirpation. Not only do reports condemn Teonanacatl, but actual
illustrations also denounce it. One depicts the devil enticing an Indian to eat the fungus; another
has the devil performing a dance upon a mushroom (Food of the Gods, p.156)

4
Modern Uses of Psychedelics in Healing
Psychedelic plants continue to be used in spiritual and religious ceremonies throughout the world.
Briefly, these include the use of the peyote cactus in the Native American Church in New Mexico, fly
agaric mushrooms among native Siberian tribes, ayahuasca tea in both traditional tribal settings as well as
within regional Christian churches in Brazil (Ratsch & Hofmann, 2005).
Indigenous uses of psychedelics have a spiritual component and appear to have what we might
call therapeutic effects even though they are not explicitly presented as such. The Native American
Church of the American southwest has been studied extensively, as have the Ayahuasca religions of
central and South America. John Halpern of Harvard University has led much of the work to assess the
effects of psychedelics among these groups. He has found that people attending religious ceremonies
with psychedelics, often hundreds in their lifetime, had similar scores on standard measures of memory
and attention, as well as on the Rand Mental Health Inventory (RMHI) as non-drug using matches
(Halpern, et al. 2005). These participants also reported positive benefits from attending ceremonies,
especially in the reduction of alcohol consumption among a population especially prone to abuse.
Despite the long history of European interaction with cultures that utilized psychedelics, they did
not enter the Western pharmacopeia until the discovery of LSD in 1943. In the late 1930s Albert
Hofmann, a Swiss chemist, was working on creating iterations of ergotamine (an alkaloid found in a
wheat fungus). Ergotamine was being used by obstetricians during the birthing process, but Hofmann
believed it could be improved upon. In the lab he would create slightly different iterations of the building
blocks of Ergotamine and test them on rats for efficacy. When he tested the 25th substance he made
(named LSD-25) he noted that it appeared to have no effect other than causing the rats to behave
strangely (Hofmann, 2009/1979).
Five years later Hofmann returned to some of these drugs to test for alternative effects. In the
process of making a sample of LSD-25 he began to feel light-headed and went home. That afternoon,
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while lying in his bed he closed his eyes and “perceived an uninterrupted stream of fantastic pictures,
extraordinary shapes with intense, kaleidoscopic play of colors.” This was the first (and accidental) LSD
experience (Hofmann, 2009/1979). The following week Hofmann self-experimented with LSD and had a
very powerful experience that interested his coworkers at Sandoz. From there, reports about the
incredible power of LSD spread quickly through the psychiatric establishment.
The first paper on LSD published by Werner Stoll in 1947 experimented with giving
schizophrenic and non-schizophrenic patients low-doses of LSD that largely resulted in euphoric effects.
This paper included a self-experiment in which Stoll reported his own extraordinary experience with LSD
(Hofmann, 2009/1979). Samples of the drug were sent to various labs around the world. The first
English-language paper on LSD was published in 1950 and titled LSD-25 as an Aid in Psychotherapy
(preliminary report of a new drug) which immediately suggested a therapeutic use of LSD (Busch &
Johnson, 1950). These papers opened a flood of research on the topic. In the following decade hundreds
of papers would be published on psychedelics during a time of extraordinary interest and progress in
psychiatric medication. LSD and psychedelics more broadly, also caught the attention of the CIA and
American military which began trials of LSD for use against Cold War enemies. The discovery of the
CIA’s clandestine program known as MK-Ultra showed that the CIA had tested LSD as a truth serum on
hundreds, if not thousands of people (for a history of this period see Lee & Shlain’s energetic book Acid
Dreams – The Complete Social History of LSD: The CIA, the Sixties, and Beyond, 1994). Information
about the damage done by this program continues to be discovered, including documents that show that
the CIA poisoned the bread in a French town with LSD which left 5 people dead, and sent hundreds to the
hospital (Samuel, 2010). Conversely, psychologists and psychiatrists that self-experimented with
psychedelics during this period led to an intense interest in psychedelics that spread into the broader
community. Aldous Huxley reported on his own experience with mescaline in his book The Doors of
Perception (1954) and various popular publications took up the topic as well, such as R. Gordon
Wasson’s article on psilocybin mushrooms in Life Magazine (June 10, 1957). The American
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government’s coincidental interest in psychedelics led to funding for many experiments across the
country and it was at was at one of these that the writer Ken Kesey first tried LSD. That experience led
him to procure LSD and begin throwing parties in and around San Francisco that came to be known as the
Acid Tests (Lee & Shlain, 1994). These parties are today considered the founding moment of 1960s
psychedelia and are among the first concerts of the Grateful Dead (for an up-close description of this time
see Tom Wolfe’s 1968 book The Electric Kool-Aid Acid Test). These powerful drugs had now spread
into broader society and became part of the growing youth movements. Reports of the negative effects of
LSD and a broader fear of these drugs led to prohibition in 1966 and the adoption of drug scheduling in
1970 (Courtwright, 2004).
In the climate of change between the first English-language publication on LSD in 1950 and the
end of psychedelic study in the 1970s a large and disjointed library of information was accrued. The lack
of standard protocols for psychedelic therapy and the challenges in creating a viable control for the
powerful effects of psychedelics made interpretation of this work challenging. I will focus on two
research threads that relate closely to the current re-emergence of psychedelic psychotherapy: the Marsh
Chapel Experiment and the studies done on the use of LSD with alcoholic patients. The Marcsh Chapel
Experiment (also known as a The Good Friday Experiment) was conducted at Marsh Chapel at Boston
University where Walter Panhke (1963) gave one group of divinity students psilocybin while another
control group received a high-dose of niacin. Niacin was chosen as an ‘active control’ because it
produces notable physiological changes. Of course, there are no true controls for psychedelics since the
effects of psilocybin are not comparable to niacin or other non-psychedelic drugs. Nearly all the students
who received psilocybin reported having profound religious experiences (Panhke, 1963) including noted
religious scholar Huston Smith who described the experience as his first personal experience of the
divine. What Panhke’s study showed was the power of preparation and environment, or ‘set and setting’.
It also suggested that under appropriate conditions it may be possible to predictably induce powerful
mystical experiences.
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The second series of experiments were conducted across North America between the late 1950s
and 1971 attempted to aid people in stopping dangerous alcohol use with psychedelic psychotherapy.
Overall, these experiments were plagued by poor and inconsistent methodologies, partly because the
methods of psychedelic psychotherapy were being developed at the time (see Mangini, 1998 for a review
of methodologies). They were halted when legislation prevented access to LSD, and the psychiatric
community became deeply skeptical of psychedelics despite the powerful testimonials of participants.
However, a recent meta-analysis of data from the most rigorous of these studies has concluded that
despite their limitations they show that a single dose of LSD within the context of psychotherapy
significantly reduces alcohol consumption (Krebs & Johansen, 2012). The landmark results of these two
programs are the antecedent and catalysts of the current interest in psychedelic therapy.
Re-appearance of Research on the Topic
Today, new research at some of the country’s most respected institutions has reanimated the field
of psychedelic psychotherapy. One of the first of these studies performed in the United States was
published a decade ago by Roland Griffith’s team at Johns Hopkins (Griffiths et al., 2006). It is worth restating their results here. Thirty volunteers were given one low and one high dose of psilocybin (at one
month apart) and their experiences were assessed soon after and 2 months after the experiences. Over
70% of participants reported having a mystical-type experience, and nearly 30% reported that these were
the single most important experiences in their lives. A follow-up study from 2011 found similar results,
with associated positive changes in behavior and attitude that were maintained after 14 months (Griffiths
et al., 2011). Since the publication of the first of these studies there has been a steady expansion of
psychedelic studies conducted at institutions across the country (For recent reviews see: Davis, 2012;
Marsa, 2014). The preliminary results of those studies are very promising. In 2006 Moreno and
colleagues published a study on the effect of psilocybin for symptoms of obsessive compulsive disorder
in 9 patients after case reports of efficacy suggested it may be helpful. Amazingly they found symptom
reductions of between 23%-100%, which mostly lasted over 24 hours after a single dose. Perhaps most
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astonishing was that the dose of psilocybin did not alter efficacy, suggesting that sub-psychedelic doses
may be just as effective (Moreno, Wiegand, Taitano and Delgado, 2006). In the last few years studies
have been published showing a very strong effect of psychedelics in the treatment of anxiety related to
terminal illness (Gasser et al., 2015), for the cessation of smoking (Garcia-Romeu et al., 2014), and in
their ability to change personality traits of openness long past the age at which personalities are thought to
become rigid (Maclean et al., 2011). In all these cases (due to federal funding restrictions) there were
relatively few participants, however, the results of each showed very powerful, statistically significant
effects.
The Goal of this Thesis
The field has expanded and yet the clinical language of psychedelic experiences has not. As of
now most social work and psychology literature has been silent on the topic of psychedelics in therapy. A
search of the PsychINFO database limited to peer-review articles published since 2000 returns only a
handful of articles on the topic. This should be alarming. Rick Doblin, a longtime advocate for the safe
use of psychedelics in therapy believes that the use of LSD for the treatment of anxiety in terminal illness
is likely to gain FDA approval in the next ten years (Doblin, personal communication).

Yet despite the

positive data and broadening public awareness of psychedelic psychotherapy there has been no
reexamination of the theoretical discourse about psychedelics to help us understand what these substances
do and how they can be used most successfully. This is not to say that earlier scholarship has diminished
in value. On the contrary, I believe that much of the work done by Stan Grof, including his seminal book
LSD Psychotherapy (1980/2008) are invaluable today. However, without an active discussion within the
professional literature I worry that psychedelics will seem too foreign or too frightening to be adopted by
practicing clinicians. This would be a profound waste of a remarkable moment for our profession.
Katherine MacLean, a research scientist on the Hopkins team, has warned that progress on
psychedelic therapy will be hampered until we can create a conversation that can include more clinicians,
both psychiatrists and therapists (MacLean, 2013). She suggested an analogy with meditation, a field that
had languished in the fringes of scientific research for decades, until Jon Kabat-Zinn began speaking of
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‘mindfulness’ in place of ‘meditation’ as a treatment for anxiety. ‘Mindfulness’ became a way of
bridging two separate communities that were skeptical of each other and that did not share a common
vocabulary. Today mindfulness/meditation has become a widely accepted treatment intervention with a
bedrock of data to justify its use in a multiplicity of situations (MacLean, 2013; Davis & Hayes, 2011).
This thesis is my attempt to bridge some of the mainstream ideas of psychotherapy with
those of the psychedelic community. My hope is that as more data in support of the use of psychedelics
emerges, we in the field of social work and psychotherapy can have a parallel conversation about how we
can use these tools and how they may affect our clients. I believe that many of our clients could quickly
gain from these therapies as most psychedelic modalities are short-term therapies consisting of between 6
and 8 visits. Perhaps ironically to some, these therapies have a long history of success as a part of
substance abuse programs, a particular vulnerability for people living in poverty (Grof, 1980/2008; Krebs
& Johansen, 2012). As therapeutic relationships are being shortened (under pressure from insurance and
government agencies) any modalities that quickly engage with the dynamic and deep-rooted causes of our
fears and pathologies will be advantageous to clients. It will be especially beneficial for those that cannot
afford to pay for therapy.
In the next chapter I will describe and define the psychedelic therapeutic experience. In chapter
three I will approach the phenomenon of the psychedelic experience through the ideas of existential
psychotherapy, using the ideas of Irvin Yalom to interpret the experiences of people undergoing highdose psychedelic therapy. This approach wrestles with the internal, subjective experience of people in the
psychedelic state. However, in chapter four we will consider what recent advances in neuroscience can
tell us about the functioning of the brain in the psychedelic state. This observational approach allows for
an objectivity that suggests the underlying biological mechanisms of both health and pathology. Finally,
in chapter five, I will consider how these perspectives, different though they are, provide a complimentary
approach to interpreting the psychedelic state. Further, I consider the implications of these findings and
what they might mean for how we understand the pathological antecedents of civilization such as
depression and anxiety.
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CHAPTER TWO
Phenomenon Chapter: Defining Psychedelic Psychotherapy
The Psychedelic Experience in Therapy
It became clear to researchers in the 1960s that psychedelics alone, while very powerful, were not
enough to predict an outcome. Some people would indeed have transformative positive experiences,
some would find themselves entertained without further positive effect, while others felt terrified and
deepened their psychological crises. As Stan Grof (1980/2008) put it in his seminal book LSD
Psychotherapy “there seems to be a general agreement at present among LSD psychotherapists that the
therapeutic outcome of LSD session depends critically on factors of a non-pharmacological nature”
(p.27). That is to say: it’s not about the drug. The psychedelic is a catalyst, but what exactly in catalyzes
depends upon a number of other variables. Most famously this was “set and setting” - meaning the mindset of the participant and the setting within which the session took place. Researchers and therapists
recognized several other factors including the relationship with the therapist (or guide) and the type of
guidance that is provided.
There are two main strands of psychotherapy with psychedelics. The first utilizes low-doses of
drug within a long-term therapeutic relationship to accelerate the therapy process. This form of therapy is
believed to increase the transference relationship and loosen defenses, thus it leans heavily upon the
relationship between client and clinician. The second is generally referred to simply as ‘psychedelic
psychotherapy’ and uses psychotherapy as a preparation for, and integration of, high-dose psychedelic
experiences. Clients are given support throughout their drug experience, however, the experience is
largely internal and not between client and clinician. This thesis is focused upon this high-dose
psychedelic psychotherapy which has been the primary subject of the recent revival in research.
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What is Psychedelic Psychotherapy?
Jefferey Guss (2013) is a professor of psychiatry and runs the psychedelic psychotherapy training
program at New York University. He defines psychedelic psychotherapy as “a collection of
psychotherapeutic processes that are facilitated by psychedelic agents”. The reason for such a broad
definition is that the psychedelics are a catalyst, and not the therapy alone. The nature of the therapy
depends on the goals of treatment. Psychedelic use in therapy is not repeated often, so the drugs are used
in discreet times and for particular purposes. For example, current studies are looking at the use of
psychedelics for nicotine addiction, death anxiety that accompanies terminal cancer, in the treatment of
depression, and for the purpose of facilitating creativity. Programs are designed specifically with these
goals in mind.
Still, most psychedelic psychotherapy protocols follow a format that is shared across research
studies. These characteristics are taken from both previously published research as well as a long
tradition of information sharing within the underground therapeutic community (see, for example, the
work of James Fadiman (2013), a noted underground therapist). The form that current methods take has
drawn from many therapeutic traditions including humanistic, psychodynamic, narrative, and cognitive
traditions. These methods also draw from shamanic and religious sources because these traditions have
explicitly identified methods to attain and manage ecstatic and mystical experiences. As Dr. Jeffery Guss
says, “What we do is not shamanic nor neo-shamanic healing, however it does absorb many of the core
teachings and wisdom that comes from these teachings” (Guss, 2013).
Conceptualization and Methodology of the Phenomenon
In this chapter I hope to elaborate on the unique therapeutic protocol used in most psychedelic
psychotherapy, as well as some background necessary for understanding these chemicals and the
experiences that they can produce in therapy. Lastly, I will briefly describe Stan Grof’s conceptualization
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of what happens in the psychedelic experience as it was (and perhaps continues to be) the most widely
accepted theoretical conceptualization of the psychedelic experience.
What qualifies as a Psychedelic & Nomenclature about Psychedelics
The term psychedelic was coined by Humphry Osmond in correspondence with Aldous Huxley.
Osmond and Huxley had been searching for a term that encapsulates the effect of the drug, and Osmond
chose psyche-delic as a compound word from the Greek words psyche (for mind or soul) and deluon
(meaning to make visible, or reveal; Hopkins Tanne, 2004). The resulting meaning is according to
Osmond “mind-manifesting” (Osmond, 1957). I have chosen to use this term because I believe it best
describes the action of these substances and avoids some of the assumptions of other ways of describing
these drugs.
Other prominent terms for these substances include “hallucinogen” and “entheogen”.
Hallucinogen suggests that they induce hallucinations, but because this is not the most prominent feature
of these drugs (some people do not get any visual distortions) I have chosen to avoid this term.
The term entheogen was coined by a group of scientists and writers that included Jonathan Ott
and Gordon Wasson and means “God within us” (Ruck et al., 1979). This was an attempt to better
capture the wide historical and cultural uses of these plants and fungi, especially in the shamanic practices
from which western science first became aware of the power. Shamanic practitioners often refer to the
plants or fungi as ‘teachers’ with whom they have dialogue. A tension exists between this shamanic
perspective and the more medical approach used in this writing. I have adopted the term psychedelic
because it is most consonant with the recent studies being done on the therapeutic potential of these
substances, but it is important to recognize the great contribution of people from the shamanic
perspectives whose work I have used throughout this writing.
In this work I deal with what are known as “classical” psychedelics. These are substances that act
upon the brain’s serotonin system primarily by activating the serotonin type 2a, 2c, and 1a receptors (for
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an in-depth discussion of the pharmacology of these drugs see Baumeister et al., 2014). These include
drugs such as LSD, psilocybin, dimethyltryptamine (DMT), and mescaline, as well as a number of
substances related to these. It is important to note that many of these substances are found in plants or
fungi, such as DMT which is the primary psychedelic compound found in Ayahuasca, mescaline, which is
found in the peyote cactus and psilocybin which is found in mushrooms. Despite the number of
substances that fit the category of “classical psychedelic” the vast majority of this work is focused on
psilocybin and LSD as they are the most-utilized members of the family.
Psychedelics can Produce Widely Variable Experiences
In the case of most psychoactive pharmaceuticals the range of possible effects is narrow and
predictable. In these cases, for drugs such as opiates or amphetamines, the effects can be easily
categorized and the underlying mechanism can be understood through pharmacology and anatomy. For
example, the release of dopamine by amphetamines attaches to receptors in cells of the mid-brain
wakefulness circuitry thus causing people to remain awake (Carlson, 2010, p.217). In the case of
psychedelics this formula is turned on its head: although many people may take the same substance at the
same dose, their experiences may be dramatically different from one another. Some may be very active,
moving about, while others may sit listlessly. Some may be lost in the geometric colors they see, others
may find themselves in a state of terror or ecstasy. Stanislof Grof, a central figure in the study of LSD
and one of the few clinicians to have administered hundreds of LSD session, described it this way:
The most astonishing and puzzling aspect of the LSD sessions which I observed in the early years
of experimentation was the enormous variability among individuals; using the same dose of the
same drug under relatively constant conditions, we obtained an extraordinary range of individual
responses in various subjects. (Grof, 1976, p.xxi)
The conclusion drawn by most clinicians working in the field is that a psychedelic experience is
not the experience of the drug, but rather of yourself in a different state of consciousness (Osmond, 1957,
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p.421). In addition, as Dr. Jeffery Guss has pointed out, any individuals experience is “embedded
inextricably in the knowledge system of the subject and guide” or clinician (Guss, 2013).
If the subjective effects of psychedelics can differ so greatly, then how do we understand what
happens when someone takes them? How do clinicians conceptualize the psychedelic experience in a
way that captures most people’s experiences and provides insight and utility in therapy? These are the
central questions I am attempting to begin to answer. Again, Stanislav Grof summarized the conundrum
this way):
LSD does not have any intrinsic therapeutic properties related simply to its pharmacological
effects. It is necessary to structure and approach the experience in a specific way to make the
emergence of unconscious material therapeutic rather than destructive. (Grof, 1980, p.281)
As alluded to in the previous quote, psychedelic experiences can be shaped by the circumstances
of session and the character and expectations of the client. These were initially described as “set &
setting” and first studied by Timothy Leary prior to his expulsion from Harvard (Leary et al., 1963).
These ideas have been collected and refined by many researchers since that time and can be summarized
in the following way: the effects of psychedelics are greatly affected by (1) the participants’ preparation
prior to the experience which includes information about the drug, a respect for its power, and a degree of
self-reflection about the goals of treatment, (2) to the participants’ state of mind at the time the drug is
taken, (3) and the environment they are in during the experience which includes the people, spaces, and
symbols, and sounds in the room at the time of the psychedelic experience (for an extensive review and
safety recommendations please see Johnson et al., 2008). Together these are referred to as “set and
setting”.
It is thanks to this malleability in preparation and circumstance that psychedelic experiences have
been conducted ritually for thousands of years, and helps create a role for these drugs in therapy. Johnson
et al. (2008) neatly summarized some of the ways in which indigenous cultures have coped with the
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unpredictability of psychedelics and the ways in which modern researchers have coopted these ideas (this
author highlighted part of the section for emphasis):
Indeed, some of the safeguards developed for clinical hallucinogen research and
expressed in the guidelines presented herein are similar to important aspects of hallucinogen use
by indigenous cultures. These common themes are structured use (expressed as ritual in
indigenous use), restrictions on use including the need for guidance and appreciation of
hallucinogens’ powerful psychological effects (expressed as reverence in indigenous use). We
believe that these commonalities are more than coincidence. The unique pharmacology of
classical hallucinogens may have shaped convergent practices across independent cultures.
(p.615)
It has been well-documented that indigenous use of psychedelics often leads participants to experience
feelings of communion with spiritual beings and to feel as though they’d gained insight about themselves
or the world (See for example Shultes et al., 2001). Re-creating these experiences is a central aim of
psychedelic psychotherapy.
Psychedelic Psychotherapy: Clinical Uses
A comprehensive protocol for high-dose psychedelic psychotherapy was fully developed at the
Spring Grove State Hospital in Maryland in the 1960s and 70s (Grof et al., 1973; Pahnke, 1969). Current
research in this field is modelled on this protocol, however, most research protocols include between 1-2
psychedelic sessions whereas clinicians at Spring Grove would often carry out ongoing treatment that
included a series of psychedelic sessions of a longer period of time. The stated goals of the researchers at
the Spring Grove Hospital were to “maximize the possibility for the psychedelic mystical experience to
occur” (Panhke, 1969, p.12) in the hope of easing their suffering. What follows is a brief overview of an
idealized protocol for psychedelic psychotherapy and is not meant as a comprehensive statement about
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them. Each study has developed their own version of this protocol to best accommodate their participants
and goals.
Psychedelic psychotherapy begins with a screening process to avoid giving these powerful drugs
to people who may be at risk from the experience. People with high resting blood pressure are excluded
because there can at times be a transient increase in blood pressure from psychedelics (information in the
section is largely taken from Johnson et al., 2008 unless otherwise noted). In addition, people taking
certain antidepressants and antipsychotic agents may be excluded as these drugs can potentiate or
otherwise change the nature of the psychedelic. Finally, people suffering from psychotic disorders or
with well-documented risk of psychotic disorder should be excluded as psychedelics have on rare
occasions precipitated a psychotic episode.
Preparation. The therapeutic program has been described by Panhke (1969) as “an LSD
session…embedded within the matrix of brief intensive psychotherapy). The pre-session meetings
consist of informing the patient/participant about the risks and effects of the psychedelic and the possible
outcomes of their experience (an elaborated version of informed consent as there are many
misunderstandings about psychedelic drugs in popular culture). In addition, a lengthy meeting is arranged
(often, an entire day) to discuss the patient/participant’s life history, struggles, goals for treatment, and to
build rapport and trust. Participants are often asked to bring mementos such as pictures that hold special
meaning to them. Participants are informed that they may encounter challenging emotions and that when
these come up they should (as best they can) resist escaping the content that is producing the emotion and
instead ‘stay with it’. Finally, a date is set for the psychedelic session.
Session Days. On the day of the session the participant is led into a softly lit and comfortable
room decorated with symbols that may hold meaning to the participant as well as natural objects to
inspire them (for example, at Spring Grove the clinicians began keeping a single stem rose in the room for
each session; Grof, 1980). At the time of drug administration participants may be asked to provide an
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“intention” for the session which may help direct the content of the participants experience (Maclean,
2014). In the room is a couch, a stereo system with headphones on which plays pre-programmed music
that encourages free thinking (often sparse instrumental music). The participant is given an eye-shade
and invited to lie down. There are two clinicians (often one man and one woman) in the room with them
for support throughout the day. These are people they met at the preparation session and are specially
trained to give aid, largely non-verbally (physical touch when appropriate). During the session most
clinicians encourage that participants ‘stay inside’, meaning keeping the eye-shades and headphones on,
as removing them can be a way of avoiding challenging content. Session days may last 10 or 12 hours
as the effects of drugs such as LSD may last as long. Toward the end of the session, as the drug effects
are wearing off, the clinicians will encourage the participant to begin describing their experience in an
effort to begin integrating it into their lives. Further meetings are held over the following day and week to
help with this interpretation and integration process.
The Subjective Experience of Psychedelics
It should be clear that individual experiences with psychedelics are heavily influenced by ‘set and
setting’ as well as the choice of substance and its dose. Yet, at the risk of complicating this format, it
must be recognized that there is often a pattern to the experience of high-dose LSD and psilocybin. This
includes an initial state of confusion, followed by anxiety or sometimes terror, which often subsides into
feelings of interest and contentment (often this includes a feeling of gaining insight or knowledge).
Finally, these high-dose experiences often cause the familiar world to appear “new” after the experience.
The following is an excerpt from Albert Hofmann’s book LSD: My Problem Child (1979/2009) and
illustrates some common experiences when LSD is taken in higher doses. Please be aware that this was
his first attempt to take LSD (in 1943) which occurred shortly after his discovery of its effects. This
experience does not reflect the way in which it is given during therapeutic intervention:

18
I had to struggle to speak intelligibly. I asked my laboratory assistant…to escort me home. We
went by bicycle, no automobiles were available due to wartime restrictions on their use. On the
way home my condition began to assume threatening forms. Everything in my field of vision
wavered and was distorted as if seen in a curved mirror. [Once home] the dizziness and sensation
of fainting became so strong at times that I could no longer hold myself erect, and had to lay
down on the sofa. My surroundings had now transformed themselves in more terrifying ways.
Everything in the room spun around, and the familiar objects and pieces of furniture assumed
grotesque, threatening forms. They were in continuous motion, animated, as if driven by an inner
restlessness…Even worse than these demonic transformations of the outer world were the
alterations that I perceived in myself, in my inner being. Every exertion of my will, every attempt
to put an end to the disintegration of the outer world and the dissolution of my ego, seemed to be
wasted effort…I was seized by the dreadful fear of going insane. I was taken to another world,
another place, another time. My body seemed to be without sensation, lifeless, strange. Was I
dying? Was this the transition? At times I believed myself to be outside my body, and then
perceived clearly, as an outside observer, the complete tragedy of my situation.
It was not until several hours later that Hofmann experienced changed:
Slowly I came back from a weird, unfamiliar world to reassuring everyday reality. The horror
softened and gave way to feelings of good fortune and gratitude…Exhausted, I then slept, to
awake next morning refreshed, with a clear head, though still somewhat tired physically. A
sensation of well-being and renewed life flowed through me. Breakfast tasted delicious and gave
me extraordinary pleasure. When I later walked out into the garden, in which the sun shone now
after a spring rain, everything glistened and sparkled in a fresh light. The world was as if newly
created.
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The Role of Mystical Experiences
“Our normal waking consciousness, rational consciousness as we call it, is but one
special type of consciousness, whilst about it, parted from it by the flimsiest of screens, there lie
potential forms of consciousness entirely different. We may go through life without suspecting
their existence; but apply the requisite stimulus, and at a touch they are there in all their
completeness, definite types of mentality which probably somewhere have their fields of
application and adaptation.” – William James, The Varieties of Religious Experience, published
in 1902
One of the most cited and dramatic reactions to psychedelic drugs are what can be termed a mystical
experience (Doblin, 1991, Griffiths et al., 2006, Panhke, 1963). These have been documented throughout
the study of classical psychedelics, and are often understood as ‘peak experience’.
Recent studies have shown that mystical-type experiences often correlate with the subjective
value of the experience (Johnson et al., 2010), the degree to which the experience triggers personality
change in the client, (Mclean, 2014), and even their efficacy in treating nicotine addiction (Garcia-Romeu
et al., 2014). It is becoming clear that these experiences may be the most effective catalysts of change for
which therapy has been designed.
In an attempt to understand these experiences William James proposed that there are 4 qualities that
differentiate a mystical experience (James, 1902, p.380-381):
1) Mystical experiences are ineffable, meaning that it “defies expression; that no adequate report of
its contents can be given in words.”
2) Mystical states also have a noetic quality, meaning that they “are states of insight into depths of
truth unplumbed by the discursive intellect.”
3) These experiences are transient, as they cannot be maintained.
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4) Lastly, mystical states are experienced passively; that is, they give the feeling that something is
happening to the person that is beyond their control, or as James put it “the mystic feels as if his
own will were in abeyance and indeed sometimes as if he were grasped and held by a superior
power.”
Based on these ideas and further elaboration by Stace (1960) a number of questionnaires have
been developed to assess mystical experiences (Hood et al., 1993). The State of Consciousness
Questionnaire (SOCQ) was developed in order to measure changes in consciousness, and to specifically
capture single-even mystical experiences like those seen in psychedelic studies (Maclean et al., 2012).
The SOCQ was developed using Pahnke’s Mystical Experience Questionnaire (MEQ; Pahnke, 1969)
which was created specifically in the use of psychedelics (Griffiths et al., 2006; Maclean et al., 2011).
The SOCQ measure mystical experience on seven domains of mystical experience originally elaborated
by Stace (1960) and borrowed here from Griffiths et al. (2006):
1) Internal unity (pure awareness; a merging with ultimate reality)
2) External unity (unity of all things; all things are alive; all is one)
3) Transcendence of time and space
4) Ineffability and paradoxicality (claims of difficulty in describing the experience in words)
5) Sense of sacredness (feelings of awe)
6) Noetic quality (claim of intuitive knowledge of ultimate reality)
7) Deeply felt positive mood (joy, peace, and love)
Following the work of previous decades (Grof, 1978) the work of the Griffiths group at Johns
Hopkins Medical Center suggest that peak or mystical experience may be the best predictor of longlasting positive change (Garcia-Romeu et al., 2014, Griffiths et al. 2008; Maclean et al., 2011). Even so,
without reaching the level of mystical experience (by giving lower doses of LSD), Gasser and colleagues
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have shown that long-lasting positive effects on anxiety in people suffering from life-threatening illness
(Gasser et al., 2014).
So how are these profound changes to be effectively pursued in the clinic? Dr. Sean House spoke
with many people involved in psychedelic psychotherapy prior to it was discontinued during the late ‘60s
and early ‘70s and asked them what contributed to efficacy of a psychedelic session. He organized these
into 5 common processes ‘in psychedelic-induced psychospiritual change’ (House, 2007) as listed below:
1) Intention – This refers to “the intent, expectation, and preparations for each psychedelic session
provide the foundation for each particular experience”
2) Ingestion – Or “the particular drug ingested and dosage”
3) Insight – The ability of psychedelics “to generate vast changes in perception”
4) Integration – refers to “the cognitive process of making meaning of the psychedelic experience
and incorporating that meaning into one’s perspectives on self and the world.”
5) Implementation – which requires “acting in ways that are congruent with what was learned”
which has been recognized as “the gold standard of psychotherapeutic success”, or differently, is
the way in which change is measured.
Indeed, these principles have been doggedly pursued by the Johns Hopkins research group headed by
Roland Griffiths and have shown that mystical experiences can be safely induced in a majority of study
participants (Griffiths et al., 2008).
Unfortunately, our conceptual formulations have not kept up with the recent and rapid pace of
research. As stated in the previous chapter, the lack of theoretical conceptualization is alarming because
these ideas are necessary for active engagement of therapists which in turn contributes to the design and
success of experiments. Just as Francis Bacon’s ideas contributed to the formation of the scientific
method contributed to the flowering of scientific inquiry during the European Enlightenment, our ideas
about the brain and psyche influence how we think about people and how we choose to approach the
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search for better methods of helping people. There is a need for us to reassess how we comprehend the
psychedelic experience both for patients (increasing predictability of their experience and better preparing
them for it) as well as for the design and utility of studies on the topic.
To this date the most comprehensive and influential model of the psychedelic experience has
been proposed and promoted by Stanislav Grof. What follows is a short description of what he developed
at length in Reals of the Human Unconscious (1976) followed by additional ideas contributed by current
researchers. Grof proposed a four-level idea about the psychedelic experience, from most superficial to
the deepest level. He further suggests that it is an oversimplification to consider a person to go through
these experiences linearly, as at any stage there may be parts of other levels interspersed (Grof & Halifax,
1977). These levels are:
1) Abstract and Aesthetic – these experiences are common in low-dose settings and include an
appreciation of changing colors and kaleidoscopic movements of shapes and forms. According to
Grof & Halifax (1977) these experiences rarely have therapeutic consequences or result in
meaningful change.
2) Psychodynamic – Grof describes these experiences as being common in psychedelic sessions and
that they are “derived from biographical material reflecting emotionally relevant situations in a
person’s past and present life” including both joyful and traumatic experiences. These can take
the form of directly re-living of experiences to “complex mixtures of fantasy and reality” (Grof &
Halifax, 1977, p.42). According to Grof, these images can come from both conscious and
unconscious parts of the psyche and may have strong therapeutic value.
3) Perinatal – According to Grof and Halifax (1977, p.46) “the most important common
denominator of perinatal experiences is their focus on the problems of biological birth, physical
pain and agony, disease, decrepitude, aging, dying, and death.” They refer to these as “shattering
encounters” leading to a “deep realization of the vulnerability and impermanence of the human
being as a biological creature” and can “force the individual to question seriously the meaning of
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existence” (Grof & Halifax, 1977, p.47-52). Grof stresses the diversity of these perinatal
experiences, but sees in them a biological basis: he believes that they are a re-experiencing of the
process of biological birth (to which he directly compares them). The perinatal experience
culminates in death-rebirth, about which I will quote at length from Grof & Halifax:
This experiential pattern is related to the third clinical stage of delivery. The agonizing
process of the birth struggle culminates; the propulsion through the birth canal is completed and
is followed by explosive relief and relaxation. After the umbilical cord is cut physical separation
from the mother has been completed, and the child starts its new existence as an anatomically
independent individual. The death-rebirth experience represents the termination and resolution of
the death-rebirth struggle. Suffering and agony culminate in an experience of total annihilation
on all levels – physical, emotional, intellectual, moral, and transcendental. This is usually
referred to as an “ego death”; it seems to involve instantaneous destruction of all the previous
reference points of the individual. The experience of total annihilation is often followed by
visions of blinding white or golden light and a sense of liberating decompression and expansion.
The universe is perceived as indescribably beautiful and radiant; individuals feel cleansed and
purged, and talk about redemption, salvation, or union with God.(1977, p.51)
According to Grof, these experiences are especially important therapeutically and can catalyze
dramatic changes in personality and behavior.
4) Transpersonal – During transpersonal experiences people feel as though their consciousness has
expanded beyond normal ego-boundaries and may encompass different times, places, creatures,
or even single cells. Some people feel themselves fully embodied as an animal or else that they
are part of the entirety of human consciousness outside of time, or as Grof put it “all of the
elements in the universe in its present form and throughout its history can be consciously
experienced by the individual.”(p#) In this transpersonal realm patients often feel that they are
watching the unfolding of consciousness and that the physical boundaries of existence cease to
matter. This can create a sense of observing the “ever-unfolding drama” of consciousness and
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limits the emotional salience of the person’s struggles which then may not require ego defenses to
protect against. The transpersonal experience is, according to Grof, also an important therapeutic
experience and is more likely to occur when more psychedelic sessions occur.
Grof’s formulations reflect his psychoanalytic training as well as the particular time during which
he formulated his ideas (“the phenomenology of psychodynamic experiences in LSD sessions is to a large
extent in agreement with the basic concepts of classical psychoanalysis” Grof, 1976, p.45). However, this
topographical arrangement of experiences has been greatly influential. Grof elaborated this model to
great depth in Realms of the Human Unconscious (year) in which he categorized the common themes of
LSD experiences in the psychodynamic and transpersonal realms. Of particular importance for this
analysis is the COEX (systems of condensed experience) which he designed to understand the
psychodynamic experiences of psychedelic sessions. Grof defined these as “a specific constellation of
memories consisting of condensed experiences (and related fantasies) from different life periods of the
individual…the memories belonging to a particular COEX system have similar basic themes or contain
similar elements and are associated with a strong emotional charge of the same quality” (Grof, 1976,
p.46). Grof understands that elements of the deep past as well as more recent memories can populate a
particular COEX, and he saw the older memories as occasioning regressive experiences. The COEX may
feel like a thread that connects experiences that are separated by years into an emotional theme. In the
LSD session these experiences are felt as happening simultaneously, hence forming the COEX. Different
COEXs may have positive or negative emotional meaning and have a tendency to take hold of the person
in a way that may make switching to a different affect very difficult. Grof believed that the memories that
constitute the COEX have great fidelity to people’s lived experience.
Within the history of psychedelic studies, Stanislov Grof is a dominant figure which may explain
why current researchers have avoided proposing competing models. Grof’s psychoanalytic language and
belief in the accuracy of both biographical (psychodynamic) and out-of-body (transpersonal) experiences
has challenged my own reading of his work. However, his formulation of the COEX system is a
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meaningful analogy for understanding how affective experience across a lifetime can collapse together
telescopically and how these experiences can be so strongly felt. If we imagine joy as not simply the joy
of any one thing, but instead all the instances of joy that we have ever felt, each of them fully experienced
together at the same moment, then you can convey some of the experiences that people undergo in these
states.
In a recent talk at the Horizon’s conference in New York City, Dr. Jeffrey Guss and Alexander
Belser presented a new conceptual framework for understanding the psychedelic experiences (Paleos.
Guss, and Belser., 2014). They are part of a group at NYU studying the effects of psilocybin on anxiety
in people facing terminal illness. During the study they struggled to find a common language to use when
discussing patient’s experiences, and particularly in finding a non-judgmental vocabulary for those
experiences (as Dr. Guss put it during his talk “in the training I received as a psychiatrist there was a lot
more emphasis placed on how to get people to stop hallucinating; nobody ever talked about LSD or
psilocybin mushrooms as anything but substances of abuse”. They devised the term ego-lytic to describe
the situation in which ego boundaries (or self-boundaries) become porous (Paleos, Guss and Belser.,
2014). They described three specific boundary situations: self/other, existence/non-existence, and
conscious/unconscious. For each of these boundaries a person may move from more to less porous
boundaries, or from egolytic to egorigid conditions, and along this spectrum the particular experiences
may create positive or negative affect. To express these situations they created the following graphical
illustrations (captured from their talk). Notice that each quadrant represents different types of
experiences, some of which may be considered pathological under certain conditions:
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FIGURE 1: self/other boundary

As the researchers point out, there is a degree to which these boundaries fluctuate over time, or
even throughout the day (for example, when daydreaming) and that we have natural capacity to alter these
boundaries. The psychedelic drugs may exaggerate this natural condition.
In some ways these maps closely relate to the topography of Grof. The psychedelic experience
can create egolytic states first in the conscious/unconscious boundary which corresponds to Grof’s
psychodynamic state, followed by a dissolution of self (in the self/no-self boundary condition) as the
“system of condensed experiences” collapses the perception of time (and may move from the “bad trip”
experience toward the “mystical experience” as labelled on the figures above), before the final state of
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rebirth dissolves self/other boundaries and leads to feelings of boundlessness. The egolysis of the self/noself boundary would correspond to Grof’s perinatal experiences, and the egolysis of the self/other
boundary may correspond to a place between the perinatal and transpersonal condition (depending on the
particular experience and interpretation of the experience). As one of their clients put it in an
accompanying video, “There was no difference between that infinite sea and me.” (Paleos et al., 2014.
P#). These concepts will be revisited in the analysis chapters to follow.

28
CHAPTER THREE
First Theoretical Perspective: Existential Psychotherapy
1Now the serpent was more crafty than any beast of the field which the LORD God had made.
And he said to the woman, “Indeed, has God said, ‘You shall not eat from any tree of the
garden’?” 2The woman said to the serpent, “From the fruit of the trees of the garden we may
eat; 3but from the fruit of the tree which is in the middle of the garden, God has said, ‘You shall
not eat from it or touch it, or you will die.’” 4The serpent said to the woman, “You surely will not
die! 5“For God knows that in the day you eat from it your eyes will be opened, and you will be
like God, knowing good and evil.” 6When the woman saw that the tree was good for food, and
that it was a delight to the eyes, and that the tree was desirable to make one wise, she took from
its fruit and ate; and she gave also to her husband with her, and he ate. 7Then the eyes of both of
them were opened, and they knew that they were naked; and they sewed fig leaves together and
made themselves loin coverings. – Genesis, book 3:1-3:7
Part of my goal is to interpret the effect of the psychedelic peak experience through the
perspective of existential theory. To set the stage for this discussion I will introduce the relevant
historical aspects of existential thinking followed by a discussion of the theoretical lenses used to
conceptualize the psychedelic experience: those of the sociologist Ernest Becker and the psychotherapist
Irvin Yalom. The background that follows is not meant to be a comprehensive presentation of those
whose work is considered existential, but rather to illuminate the guideposts that have led to my own
formulation of this field and to hint at the context within which existentialism developed.
That death is the inevitable corollary of life continues to be the central engine of existential
thought. Almost universally, existential thinkers assume that there is no continuity of our ‘selves’ beyond
corporeal death (i.e. a soul). Existentialists argue that this completeness of death, its utter contradiction
with what came before, must change how we live.
Humans may be uniquely aware of mortality; able to witness, describe, and convey its frailty in
words.

Yet we are animals that possess the unique ability to use language which has allowed us to see

the world from god-like vantage, to pass on knowledge and control our environment, but also to become
aware of life’s inevitable end. Thus, like Adam and Eve, we may have discovered the fruit to know good
and evil and in this way we are like Gods. However, we also carry with us the foreknowledge of our own
deaths, and this knowledge haunts us.
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Although death has long been a thematic obsession of human cultures, it was the 19th century
European interest in the experience of the individual (e.g. Kierkegaard and Nietzsche) that differentiated
this period of thought. Nietzsche’s story of the madman who yelled “God is dead…we have killed him!”
dramatized the changes brought about by the weakening influence of the church in Western Europe.
Religious power had forcefully crushed discussion of topics that could be considered heretical. Without
ideological policing, many viewpoints were brought into public conversation, including agnostic and
atheist positions.

Nietzsche and others argued that if there is no God then there cannot be any objective

value system. Rather, most people absorb the values of the culture within which they live without
examining them. Nietzsche and Heidegger saw it as the project of each individual to discover their values
and to pursue a life that is in line with those values. This is both a terrifying and freeing proposition: we
are able to create the meaning we take from our lives, but we may also succumb to the yawning abyss of
the indifferent, valueless, and meaningless world around us.
Parallel to this the twin 19th century development of psychology as both a science and a healing
method made our experiences grist for analysis. Finally, in the early 20th century the trenches and ovens
of Europe led many people to question the institutions and ideologies from which they had previously
drawn meaning.
The ideas that death is both inevitable and permanent, and that humans are uniquely aware of
their mortality are the baseline assumption of existentialism. Existential thinkers became popular in the
post-war period as a way of managing the terror of the war years in Europe. From this starting-point
existentialists have mapped the ways in which humans have built their lives (and societies) in the shadow
of their own mortality.
Background on Existentialism: Developments in Social Psychology
This personal quest for understanding and meaning promoted by the early existentialists became
important during the destructive first half of the 20th century. Both world wars served to destroy the
empires, nation-states, cultures, and institutions that created meaning for many people of Europe. The
very structures that Kierkegaard and Nietzsche had railed against were now gone or hobbled. In that
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destructive moment all value and truth became relative. Like someone who has come close to death and
survived, Europeans were then tasked with re-assessing the meaning of European culture, how it had led
to a near-suicide, and for deciding, as individuals, what they believed and who they were. But what
information could they use to make these decisions?
That death could be sudden, random, and purposeless, that so many people could be lost in so
short a time, that justice and ideology could feel so alien, forced a tremendous reevaluation in the hearts
of many people. Some of the greatest literature of this period attested to the struggle for meaning after
terror; see for example All Quiet on the Western Front by Erich Maria Remarque (1929), Ernest
Hemmingway’s The Sun Also Rises (1926) and The Plague by Albert Camus (1947).
In the wake of the World Wars, western writers, sociologists, philosopher, and psychologists
attempted to understand how seemingly sane people could, as the Nazi Germans had, perpetrate mass
murder and what such behavior meant about humanity. Some notable works in this vein were those of
Hanna Arendt, Staley Milgram, Albert Camus, Viktor Frankl, and Rollo May. Indeed, Frankl and May
both survived the Nazis and went on to develop therapeutic approaches based on their conclusions about
life and meaning. They both sought to understand the ways in which people manage anxiety and fear in
their psyches. It was Frankl’s experience in a German concentration camp that led him to reflect upon the
way in which people formulate meaning as a way to combat the despair caused by the meaninglessness of
life (see Frankl, 1946/2006).
However, it was Ernest Becker who applied these analyses more broadly into a consideration of
how the very structure of society allows us to escape the fear of death. His writing often echoes
Nietzsche and Kierkegaard in regard to the terror of living without the grounding effect of social ideas.
In his most celebrated book, The Denial of Death (1973/1997), Becker lays out his formulation
which I will present briefly here because of the value that his position has had for my understanding of
psychic development. Becker began by pointing out that humans are animals, and as animals we have
evolved to manage the threat of death. From a Darwinian perspective there are two main drives for
individual behavior and evolution: the drive to stay alive and the drive to procreate. Indeed, the fear of
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death is an instinctual learning mechanism in mammals so that they can recognize threat, as when a
squirrel associates a barking dog with threat. Of course, humans have this too and according to Becker
“this fear [or terror] is actually an expression of the instinct of self-preservation, which functions as a
constant drive to maintain life and to master the dangers that threaten life.”(Becker, 1973, p.42). Whereas
animals often use their physical attributes such as strength (elephants), speed (rabbits), or chemical means
to protect themselves from an early death (skunks, poison dart frogs), humans are naked apes and have
little in the way of these attributes. Instead, we have an intelligence and communication ability that
allows us to imagine the future and work cooperatively to protect ourselves with clothing, guns, and
medicine (Salomon, 2011).
However, these abilities also produce unexpected consequences. We have a unique problem in
nature: because of our intelligence we become aware of our own mortality, that the end is definite, and
can imagine all the terrifying ways in which one may die. This paradox was described by William James
in his Varieties of Religious Experience:
In short, life and its negation are beaten up inextricably together. But if life be good, the negation
must be bad. Yet the two are equally essential facts of existence; and all natural happiness thus
seems infected with a contradiction. The breath of the sepulcher surrounds it…the fact that we
can die, that we can be ill at all, is what perplexes us; the fact that we can now for a moment live
and are well is irrelevant to that perplexity. We need a life not correlated with death, a health not
liable to illness, a kind of good that will not perish, a good in fact that flies beyond the Goods of
nature. (James, 1902, p.108-109)
Because of this problem humans must come up with a unique way of managing what could
become overwhelming terror. The central question is: How, in the face of the absolute knowledge of our
own death, can we continue as though everything were fine? Or as James put it, how do we find “a health
not liable to illness”? Becker suggests that we repress thoughts of death with the aid of cultural identities
that build self-esteem. Cultures also give us methods of symbolically achieving life beyond our death:
people continue to ‘live on’ through their children, through their works, and by identifying with
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institutions such as countries or professions. He points out that “all historical religions addressed
themselves to this same problem of how to bear the end of life” (Becker, 1973/1997, p.22) and that
society and religion provide for us many ways to live beyond our own lifetime both symbolically and
literally (e.g. afterlife). In Becker’s telling, by achieving socially agreed-upon goals such as professional
success and recognition within our communities, we also develop self-esteem. This self-esteem acts
internally to insulate us from thoughts of death.
A group of sociologists led by Sheldon Solomon and Jeff Greenberg have developed Becker’s
ideas into Terror Management Theory (TMT) from which they were able to test the hypothesis that
increasing a person’s awareness of death (mortality salience, MS) would lead to a deepening connection
with parts of their cultural identity and self-esteem that protect them from MS. Indeed, studies have
found that unconscious reminders of mortality lead to people feeling more closely connected to their
country, religion, and political views. Conversely, people become more aggressive toward people from
different countries, religions, or those who hold different political views (reviewed in Greenberg and
Arnedt, 2011). The second defense of self-esteem acts similarly, with participants recommitting to
extrinsic goals such as career and financial goals when presented with mortality reminders. Interestingly,
these results rely on having the MS be unconscious. When people are reminded of death they first react
by reducing extrinsic goals, only to inflate them once the mortality reminder escapes consciousness
(Kosloff and Greenberg, 2009).
Existential Psychotherapy and the Psychology of Death Awareness
The American psychotherapist Irvin Yalom (1980) is the most successful exponent of existential
psychotherapy, and the sections that follow are largely based on his text Existential Psychotherapy.
Yalom’s existential psychotherapy was developed in the psychodynamic tradition that began with Freud.
As I use it here psychodynamic refers to the belief that there are internal conflicts within us at varying
levels of consciousness that shape our behaviors and emotions. However, Freud sees the central conflicts
arising from suppressed instincts (especially sexual and aggressive urges). However, Yalom and his
acolytes see the central conflicts of personality arising from ultimate concerns, “the givens of existence”

33
(p.8) first among them is death. The four ultimate concerns in Yalom’s constellation of conflicts are:
death, freedom, isolation, and meaninglessness. A conflict exists between our knowledge that death is
inevitable and our desire to continue to live. So when a person becomes aware of these ‘ultimate
concerns’ they respond with anxiety. The awareness that death is an end to consciousness results in a
confrontation with nothingness, the terrifying abyss. To protect ourselves from anxiety we develop egodefenses that “restrict growth and experience” (p.10) which can lead to psychopathology.
In Yalom’s view, most people develop “denial-based strategies such as suppression, repression,
displacement, belief in personal omnipotence, acceptance of socially sanctioned religious beliefs that
“detoxify “death, or personal efforts to overcome death through a wide variety of strategies that aim at
achieving symbolic immortality.” (1980, p. 111). He considers this a normal developmental step, yet
some people experience death anxiety so acutely that it spills into other realms of their experience which
causes a reliance on these defenses. Yalom (1980) gives the example of a client who compulsively
participated in extramarital affairs that produced a masking anxiety that prevented interrogation or
confrontation with the root death concerns.
Death Anxiety and the Psychedelic Peak Experience
Death anxiety is common as clients approach the peak psychedelic experience. The following
passage is a patient’s description of his psilocybin experience while participating in the Johns Hopkins
psilocybin study (Maclean, 2014; sections highlighted by this author):
These are my visceral fears, I know that now. I experience them one by one and together in
combination with the intensity of an electric chair. First there is the pain. Things hurt. My right
elbow hurts and my back hurts, but it is all drawn together by my blood hurting. My blood is
gone and I know it is my life-force. I want it back to make the pain go away. The pain is maroon
and purple or devoid of color. Then there is the agony. It comes in waves and I am having
trouble writing about it. The agony has no color. I am afraid of it and don’t understand why it
exists. All at once I feel it again and again. Every cell in my body hurts. I feel this as real. The
pain is real like I am being electrocuted. The life force is in me and swells in me during the
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waves of agony, and also shoots out of me so that the room is also in agony. Everything is. My
guides are with me and are in the same energy, but they can’t feel it. I’m so happy that they can’t
feel it. I want to take the agony away from everyone. I’ll take it I say. I want the agony so that
somebody else doesn’t have to feel it. I do not understand why this is happening or why I would
create this for myself. I’m abandoned and not taken care of. I feel like an inch of my blood is
taken from my body as I lay on my back. I don’t feel blood in my hands; I think there are holes
in me and I am dying. I know I’m supposed to embrace the dying and my guides remind me but
I can’t breathe. Everything is heavy on me and the world, like an ocean of energy, is on me.
And I am dead. I don’t like it. I stay dead for a while and it is full of dark emotion but full.
Death is a lack of control and I don’t like it. Death is the end of beauty; death is the
unknown. Despair. It is the desire that is the problem, I say. This means that I want
approval that I can’t get. I want to be interesting and special and normal, all at the same time.
The problem is [that] I want these things but I don’t want to want them. I so just want to accept
whatever is. The desire vibration/sound turns into selfishness, guilt and despair. Nothing is real,
nothing matters, nothing I do will matter. There is nothing. Despair is black and so am I. Then it
gets horrible. I generally feel that everything is not going to be ok. I am not going to be ok, and
nobody is going to be ok. I am reassured that I am going to be ok, but I don’t believe it. I even
know it is the psilocybin, and I still don’t feel that things will turn out fine. This is one of the
most horrible things I have ever felt. I was afraid of the fear and felt out of control.
Katherine Maclean (2014) explained that this patient felt “shell-shocked” that evening and the following
day. However, a week later he “felt invincible”, and now, a year after his experience, he feels that it has
“permanently changed his life” for the better.
For many participants death anxiety in the psychedelic state culminates in ‘ego-death’: an
experience of dissolution followed by a profound calm and sense of unity with the world. This
breakthrough experience of a shattered ego-self is what we call the mystical experience which is thought
to be the source of healing in psychedelic psychotherapy. Yet, in the story I presented above there was no
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such release during the psychedelic experience. It was not until several days later that the patient came to
feel the positive impact of his experience, one which he now believes changed his life for the better. It
would seem that healing can exist without a mystical experience. It may be that it is the naked
confrontation with death anxiety that has given him healing. This is in line with Yalom’s approach in
psychotherapy as he sees death awareness as an important therapeutic tool which creates “a radical shift
in life perspective” (Yalom, 1980, p.154). He explains that confrontations with death anxiety “propel one
into a confrontation with one’s existential situation in the world” which “has the power to provide a
massive shift in the way one lives in the world” (Yalom, 1980, p.159). Indeed, this is what we see with
psychedelic psychotherapy.
In Ernest Becker’s formulation, we use our identity and self-esteem to protect from the
subconscious threat of death anxiety. Our identity expands from our core self to encompass our social
roles such as our profession, our family identity, and our cultural and national identities. When we feel
threatened these identities reassert themselves to protect us from mortality concerns. Or as Yalom puts it
“the neurotic not only protects his or her core but defends many other attributes (work, prestige, role,
vanity, sexual prowess, or athletic ability) with the same intensity” as their core selves (Yalom, 1980,
p.163). The loosening of these identity markers (both social and personal) can help explain some of the
results of psychedelic psychotherapy. As Maclean et al., (2011) have shown, adult participants in
psilocybin trials show increases in the personality trait of openness as measured by both self-report and
interviews with family and friends. People who experience ego-death no longer seem to feel the need to
protect their identities so closely which allows them to increase their openness to new ideas and
experiences since there is no cost to their worldview or self-image.
Contrary to my argument, many people who experience serious confrontations with death anxiety
such as near-fatal illness, violence, and trauma, do not feel freed from their anxiety but rather develop
serious pathologies such as anxiety, post-traumatic stress disorder, and depression. How can we square
the very opposing results of intense death anxiety? In response to what they see as a cynical worldview of
many TMT researchers Martin, Campbell and Henry (2004) advanced an idea that helps unify both ideas.
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They collected experiences of people who have experienced near-death experiences, as well as people
diagnosed with fatal illness. They found that two groups emerged: those people for whom the
experiences triggered severe anxiety and pathology, and those for whom they resulted in growth,
openness, and a positive worldview. Based on these works the authors hypothesize that two components
affect the outcome: the person’s belief that death was imminent, and the acceptance of this result. The
more life-threatening the event, the more likely people were to acquiesce to their fate, and in doing so
they gained greater positive aftereffects, became more open, and felt more at ease after the encounter.
Additionally, the ever-growing literature on post-traumatic growth underlines some of the ways in which
confrontations with death can be positive inflection points in a person’s life.
Psychedelic psychotherapy is conducted under conditions that would match the hypothesis of
Martin, Campbell, and Henry (2004): patients are given a relatively high dose of psilocybin that
overwhelms the ego and they are instructed to accept uncomfortable experiences by ‘going toward’ their
anxiety defenses (Johnson et al., 2008). If these two conditions are met then patients have a high
likelihood of experiencing ‘ego-death’ and a full mystical experience which has been shown to correlate
with significant improvements in psychological health. Additionally, because such experiences can be
consistently induced under controlled therapeutic conditions, they may allow patients to gain the insight
and power of near-death experiences without significant risk.
The existential perspective can help anchor and name the often difficult experiences that people
undergo during psychedelic psychotherapy. These experiences are inherently idiosyncratic and peculiar
to our biography and temperament. That these experiences follow a pattern despite the variability
inherent in psychedelics is itself remarkable. In the next chapter I will present a perspective based on
neuroscientific research which uses observational data to better understand the nature of the psychedelic
experience. The biological explanation complements the existential perspective and roots it in the
physical nature of the body and brain.
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CHAPTER FOUR
Second Theoretical Framework: Neuroscience
Introduction to Neuroscience
Neuroscience is the scientific study of the brain and spans topics such as anatomy, physiology
and chemistry. Neuroscience can be a good explanatory tool when used to help uncover how the
underlying biology of the brain affects our perceptions and actions. People imbue neuroscience with a lot
of power and it can also help clients understand/conceptualize what is happening to them as external. For
example, conceptualizing adolescence as a time period during which the prefrontal cortex, an area
important for planning behaviors, is underdeveloped helps prevent blaming adolescents for behavior that
is normal during this time period. Additionally, neuroscience can help to root our subjective experiences
in the observable phenomena of the brain. This is particularly important for placing the psychedelic
experience onto sure footing. Because psychedelic experiences are unique both to the individual and the
moment, it can be a challenge to explain what is going on. Nonetheless, by using careful methods and
newer physiological measures of brain activity researchers can formulate hypotheses about the therapeutic
effect of psychedelics.
It’s important to note that there is a risk of using neuroscience explanations. Because so much
faith has been put in the work of scientists, the use of biological terms can mask poor explanations (see
for example Weisberg, Taylor, and Hopkins, 2015). People without a neuroscience background find
explanations ‘seductive’ when they refer to actions of the brain. Still, judicious use of biological
explanations can help inform theoretical and conceptual frameworks about mind and behavior.
One of the reasons that neuroscientific explanations have such power is their ability to decipher
the ways in which our experiences are constructed by the brain. Various experiments and case studies
have shown that although we feel as though we experience the world directly, it is the brain that creates
the world we experience. For example, the perception that our consciousness resides in our head is
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constructed by brain mechanisms. In 2005 Blanke and Arzy showed that stimulating a small region in the
area just behind the ears can lead to perceiving the world from outside the body. These induced out of
body experiences (OBE) help underline the degree to which our world is created through biology.
In the last few decades scientists have gained the ability to observe real-time activity in the brain
as subjects perform various tasks such as reaching their arms, listening to music, or speaking. The most
popular such method is known as Functional Magnetic Resonance Imaging or fMRI. Much of the data
described in this chapter has been obtained using fMRI methods which look for brain ‘activation’.
Regions of ‘activation’ or higher metabolic activity are determined by the relative amounts of oxygen
consumption in different parts of the brain (see Raichle & Mintun, 2006). Increasing consumption of
oxygen is a marker for metabolic activation that results from the increasing demand from neurons that are
firing. Activation of a brain region while performing a specific task (when compared to control) suggests
that this region is important in completing the task. For example, fMRI can show the activation of the
visual cortex (at the back of the brain) when people are being shown images or are being asked to use
visual imagination which contributes to the argument that this region is important in image formation.
Advances in fMRI technology and understanding of brain dynamics have changed the way in
which scientists study the brain. One such change relates to the emergence of neuronal networks that
perform activities instead of singular brain areas. Scientists have found that networks of neurons spread
around the cortex (the outer part of the brain) work together to perform common tasks such as speech
production. When studied in the fMRI the regions involved appear to become active together and
inactive together when the subject is resting. This co-regulation is known as network coherence or
functional connectivity which can describe how closely linked different regions of a network are (for a
review see: Snyder & Raichle, 2012).
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The Default Mode Network (DMN)
In 2001 it was accidentally discovered that there is a cortical network that becomes active during
a relaxed resting state (Raichle et al., 2001). In most experiments using fMRI this was considered the
‘control’ condition because no task was being performed. However, the brain was behaving as though a
specific task was being done. This network came to be known as the Default Mode Network (DMN) and
is one of the most actively studied brain networks. Indeed, it is the discovery of the DMN that allows us
to consider how the brain creates self-perception and thus allows us to consider the brain’s role in the
psychedelic state.

FIGURE 3: Regions of color represent the areas that make up the DMN
In the nearly 20 years since its discovery there have been hundreds of studies to elucidate the
function of the DMN. In general this network is active when people are thinking about the past,
imagining the future, letting the mind wander, and during self-reflection. A number of researchers have
suggested that the DMN is the physical substrate of the ego, and the functions of each of the parts of the
DMN support some of these ideas.
The DMN is divided into three regions. The first (1) is found at the front of the brain along the
middle and toward the bottom is called the ventromedial prefrontal cortex (vmPFC). The next (2) is just
above this region, also along the midline of the brain but closer to the forehead called the dorsal medial
prefrontal cortex (dmPFC), and finally (3) the regions further to the back of the brain that includes the
posterior cingulate cortex (PCC), lateral parietal cortex. Further detail can be found in Raichle et al.,
2001.
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These three regions have been implicated in different functions that combine to form the DMN
(Raichle, 2015). Region 1 responds most to anxiety created by learning a new task, and its activity
decreases as the task becomes easier. It seems to relate to emotional processing. Region 2 reacts to ‘selfreferential judgement’ or making a judgement about an internal feeling (feeling pleasant or
uncomfortable). Region 3 is most active in recollecting prior experiences, or drawing on memories. The
three regions become active together with each of the 3 regions adjusting when a task is more demanding
of them (for example, when being asked to recall a prior event region 3 may become more active).
The DMN appears to be the Brain Network that Constructs the Ego
If Raichle (2015) is correct that the DMN is a “self-centered predictive model of the world”
which considers both the past and tries to imagine the self into the future, then we see that it closely maps
over some of the main functions of what we consider the ‘ego’. The DMN contains strong neuronal
connections to a very wide range of brain regions, which is suggestive of the importance of this network.
That self-reflection is the primary activating task of the DMN also points to the possibility that this
network underlies self-perception and may be involved in pathologies with altered self-perception.
Posner and colleagues (2013) have shown that functional connectivity or network coherence of
the DMN is increased in depressed patients and is suggestive of rumination. Furthermore, they found that
when patients are stabilized with antidepressants the DMN behavior normalizes. Likewise there is
growing evidence of DMN disorganization in people diagnosed with schizophrenia (Wang et al., 2015).
Psychedelics and the DMN
The upsurge in work studying the DMN has coincided with a loosening of regulations on
studying LSD and psilocybin in human subjects. In the last several years Dr. David Nutt and Dr. Robin
Carhart-Harris have been able to study subjects under the influence of LSD and psilocybin in an attempt
to understand what is happening in the brain after a moderate dose of psilocybin. These studies have
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implicated the DMN in the changes associated with peak psychedelic experiences and suggest a
hypothesis of how changes in brain activity may underlie the subjective effects of these drugs.
In 2012 this group published a surprising first finding: when subjects were given psilocybin there
was no increase in brain activity. On the contrary, the group found a decrease in brain activity
specifically the PCC and mPFC both dorsal and ventral (both important parts of the DMN), and additional
decreases in the thalamus (Carhart-Harris et al., 2012). There are two valuable clues in this finding: the
first is that all three of these regions are major hubs of connectivity in the brain akin to Penn Station in
New York – a place where lots of information is trafficked. Second, it is notable that the part of the DMN
that was not affected by psilocybin is the lateral parietal cortex, a region very important for accessing
memory. Notably people report increased access to memories during the psychedelic state and often
remember their experiences in minute detail. Participants were also asked to rate the strength of their
psychedelic experience and the strength of their subjective experience was strongly correlated with
reductions in activity in the DMN regions. These results suggest that the primary impact of high-dose
psilocybin is to reduce activity in much of the DMN and that this decrease may be responsible for the
uniquely psychedelic experiences.
Similar reductions in activity of the DMN were seen under the influence of LSD (Carhart-Harris
et al., 2016) and upon further analysis the researchers found that LSD dramatically reduced
synchronization of the cortical neuronal networks, and that the greater the reduction in synchronization
predicted stronger psychedelic effects. Notably, desynchronization was strongly correlated with feelings
of ego-dissolution but not visual hallucinations.
Recognizing that the DMN regions that were de-activated after psilocybin and LSD are major
hubs of connectivity, Petri et al. (2014) studied what happens to the functional connectivity between brain
regions. As described earlier, the brain is organized into several important networks made up of diverse
brain regions that act together to carry out a task, among them is the DMN. Scientists study these
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networks by looking at ‘functional connectivity’ between different regions which show which regions act
in synchrony becoming active or inactive at the same time. Petri and colleagues found that by shutting
down the hubs of the DMN, psilocybin led to a remarkable increase in connections between disparate
brain regions. The image below illustrates a large increase in connections being made between disparate
brain regions (psilocybin condition is on the right). The size of the circles represents the strength of the
connection between these regions. You can see that there are many more strong connections in the
psilocybin condition which suggests a larger amount of integration among regions and fewer large
networks dominating cortical brain activity[JL1].

FIGURE 4: Comparison of neuronal connections during normal waking consciousness (left) and
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subjective effects of ego dissolution (as measured through well-studied self-report questionnaires) makes
a powerful case for the involvement of the DMN in peak psychedelic experiences. Indeed, it suggests
that the mystical nature of peak experiences is a product of the physical brain as opposed to transpersonal
forces. That these experiences are felt as transpersonal, as though connected through a ‘life-force’ to all
other creatures across time, is certainly true and should not be undermined by these findings. I would
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argue that these data suggest an incredibly compelling reason to believe that the human brain is
constructed in such a way as to have access to these important and life-affirming experiences.
How Can We Understand the Value of DMN Deactivation and Increased Brain Connectivity?
Aldous Huxley famously described his first psychedelic experience in his essay “The Doors of
Perception” (1954) in which he also propose a hypothesis about the actions of psychedelics. He wrote
that the amount of information entering the brain through our senses was far too much for our conscious
mind to comprehend, and this huge amount of incoming data would also trigger biographical and factual
associations of memory which add to the volume of information. Huxley believed that this staggering
amount of information would overwhelm the conscious mind. Instead the conscious mind acted as a
“reducing valve” (Huxley, 1954, p.8) or filter to focus the mind on the most relevant information for
survival. We have learned since then that the brain determines which information is relevant to the
current situation and where to bring conscious attention based on past experience and physiological
desires such as hunger, sex, and fear. However, under the influence of psychedelics these filtering
systems break down allowing the conscious mind to access a huge amount of information. This added
information likely contributes to the significant increase in new cortical connections seen in the Petri et al.
(2014) figure above.
It is worth noting that the thalamus, which is also consistently deactivated under the influence of
psychedelics, is the primary gateway for nearly all sensory information aside from smell (Herrero et al.,
2002; McCormich and Bal, 1994). Deactivation of the thalamus likely results in the unbridled flow of
sensory information to the cortex and thus likely contributes to the intense, confusing, and sometimes
frightening experiences that people have while under the influence of psychedelics. Further evidence for
the importance of the thalamus can be found in people with schizophrenia. It appears that during active
hallucinations the thalamus becomes overactive, thus providing false sensory input to the cortex that
mimic real sensory information (Behrendt and Young, 2004).

The strong connection between the
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thalamus and mPFC may explain some of the boundary confusion that exists for people with
schizophrenia. When aberrant or false sensory information enters the mPFC (part of the DMN) patients
experience these ‘external’ stimuli as part of their constructed self.
If we now consider the possible effects that result from the twin changes in the thalamus and
DMN I believe we can begin to interpret the subjective effects that lead to ego-death. During this time
unfiltered sensory input bypasses the thalamus and streams into the cortex (where consciousness is
constructed). At the same moment the disintegration of the DMN results in the loss of ego boundaries.
The rush of un-gated sensory and autobiographical information into consciousness are likely to increasing
the intensity of the experience and may contribute to the feeling of being fully immersed, even engulfed
by the moment. Furthermore, as the DMN begins to deactivate, two things happen: cortical regions begin
to connect in new and unique patterns thus bridging ideas and perceptions that would otherwise remain
separated, and self-other and conscious-unconscious boundaries dissolve. This new, boundary-less
position means that feelings of the self are unbound, thus leading us to associate the self with any
perceptions, memories, or ideas that pass through awareness. With the near-total dissolution of the DMN
under high-dose psychedelics the entire content of the mind becomes part of the self-perception resulting
in feelings that the self-expand as far as the mind. This transcendence of time/space is one of the four key
components of a peak or mystical experience (Maclean et al., 2012).
Neuroscience has given theorists a wealth of ideas to help interpret the psychedelic experience. It
is worth noting that even these more objective metrics such as neuronal activity require conceptual
interpretation. Despite significant strides in developing coherent explanations for the effects of
psychedelics our understanding of the biology of these substances is still woefully under-researched. In
the next chapter I will step back and attempt to synthesize this neuroscientific perspective with the
existential ideas presented earlier. In addition, I will discuss some of the far-reaching implications of
these ideas on our view of health and pathology.
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CHAPTER FIVE
Discussion
The use of psychedelics in ceremonial or therapeutic contexts has a long history in human
cultures. Although not without risk, it is an old and powerful method of healing. The re-emergence of
research on the topic has ignited popular discussion, but very limited consideration among clinicians.
Several ongoing clinical trials are moving these drugs toward eventual approval, increasing the need for a
thorough consideration among mental health clinicians. The goal of this thesis is to consider theoretical
frameworks for understanding the psychedelic peak experience.
Both the existential and neuroscientific approaches hold value for interpreting and managing
high-dose psychedelic experiences in the therapeutic context. Indeed, I see these perspectives as
complementary even as they view the question from different levels of analysis. Existential perspectives
may scaffold clinical interpretation of our client’s experience and in turn give clients a language with
which to understand the profound and otherworldly journey of psychedelics. In contrast, the
neuroscientific perspective ignores the individual experience instead focusing on the statistical and
biological similarities among people’s experience. It may be that a more objective, medical frame will
help draw people skeptical of the personal narratives that populate most theoretical orientation.
Nonetheless, there is still a lot that we don’t know about the therapeutic potential of psychedelic
experiences. There are still too few studies of psychedelic psychotherapy, and although most are welldesigned, the small number of participants makes it hard to make more specific recommendations.
Studies have not compared alternative preparation sessions or methods of post-treatment integration.
There needs to be a greater understanding of how meaningful experiences are translated into new patterns
of behavior that provide meaning to clients. Aside from the exclusion of people with psychotic illness,
there have not been rigorous considerations of the value of psychedelic psychotherapy in diverse and
persistent pathologies such as OCD or narcissistic and borderline personality disorders. When these
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studies are completed they may help us better assess and understand the methods by which psychedelics
can be healing and the limits of their utility.
High-dose psychedelic treatment requires a peculiar amount of focus and scaffolding: they are not
passive pharmaceuticals that act independently of patient’s mindset such as blood-pressure medication or
even classic anti-depressant medications. On the contrary, psychedelics demand participation and can be
seen as an adjunct to classic psychotherapeutic treatment.

I have not discussed the clinical context of the

psychedelic experience, yet the quality of the therapeutic relationship and both preparation and integration
of sessions is paramount to successful treatment.
Theoretical Considerations and Conclusions
One of the complementary findings from therapeutic and brain scan studies is that diminution of
the ego-related processes is one of the primary effects of psychedelics and that they may underlie the
success of treatment. That the diminishment of self, either through confrontation with mortality or the
experience of ego-death, is felt by many people to be a profound and enlightening experience suggests
that it may be the very existence of the ego that causes suffering. This is supported by the observation
that humans have found many ways to escape, forget, or expand the sense of self through alcohol, drugs,
meditation, or the pursuit of extreme experiences. While self-awareness is an important evolutionary tool
for communication and cooperation, the hyper-focus on oneself demanded by an individualist,
consumerist culture may be the seed of suffering.
There is significant phenomenological and scientific evidence that ego-focused rumination
contributes to depression and anxiety, and reducing self-awareness and thinking is experienced as
relieving. As mentioned previously, depressed individuals often ruminate on their struggles which can act
to reiterate and maintain a depressive mindset. This rumination, or repeated negative thinking about
oneself, is correlated with increased activity in the DMN, a pattern that is reversed with successful
antidepressant treatment (Hamilton et al., 2015). Conversely, a number of studies have suggested that
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compassionate, altruistic behavior is strongly associated with health and happiness (reviewed in Post,
2005).
David Loy, a Zen Buddhist teacher and philosopher, has written about the Buddhist perspective
on self. According to Loy, Buddhist doctrine sees the idea of the existence of any ‘self’ to be an illusion
of language wherein self and object must be divided (Loy, 1996,p. xiii). As a result of this we live with
an anxiety that we are indeed an illusion, what Loy calls a ‘sense of lack’ (Loy, 1996, p. xv). This feeling
of lack is a root, or fundamental anxiety that drives our minds to seek satisfaction in our appetites. These
ideas can be important when considering both the meaning, and methods of attaining satisfaction and
happiness. I am pleased that psychologists have begun bridging these Buddhist concepts with the current
psychological literature (Shiah, 2016). I hope that they may provide a foundation to the goals of
psychotherapy.
Continuing, I propose that when people face the experience of dissolution during a peak
psychedelic experience they confront this root anxiety of self/no-self. Having faced and surpassed the
anxiety people feel an extreme sense of liberation and joy, as if seeing the world for the first time. The
liberation of self, described as “oceanic boundlessness” is both a complete loss of self as subject while
also seeing self in all things. The joy that comes from such a fundamental experience often changes
peoples’ understanding of themselves and the possibility of their lives. As Maclean and colleagues
(2012) have found, not only do subjects often experience healing but those who experience a ‘complete
mystical experience’ become more flexible and open to new experiences as though freed from the
confines of rigid ego defenses.
It strikes me that people seek such experiences of self-loss in many ways. These are the
obliteration of self when we see images of the earth from far distances such as the moon. It gives the
visceral sense that we are small as to not exist at all. We are awed by the Grand Canyon, by enormous
mountains, and brilliant sunsets in a similar fashion. We ‘forget ourselves’ through concentration in
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music or other passion (“flow” experiences), and in inebriating drugs such as alcohol and heroin. In
Buddhist meditative practice people experience no-self on the path of liberation. One recent example can
be seen in the experience of Christopher Thomas Knight, known as the North Pond Hermit, a man who
chose to live in the woods of Maine for 27 years without contact with other people. He lived alone in the
pine woods by stealing food, clothing, supplies, and alcohol from nearby cabins (which terrorized local
residents). Interviewed by a reporter, Mr. Knight, who was in prison at the time, tried to describe the
result of his experience alone in the woods:
I did examine myself," he said. "Solitude did increase my perception. But here’s the
tricky thing—when I applied my increased perception to myself, I lost my identity. With no
audience, no one to perform for, I was just there. There was no need to define myself; I became
irrelevant. The moon was the minute hand, the seasons the hour hand. I didn’t even have a
name. I never felt lonely. To put it romantically: I was completely free
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